For Patients

Clinical Trials

Avelas Biosciences is currently enrolling a phase 1b clinical trial for AVB-620 in women with primary, non-recurrent breast cancer undergoing surgery

Please find additional information regarding this trial at https://clinicaltrials.gov/ct2/show/NCT02391194

For further information, please email us at contact@avelasbio.com